Prostate adenocarcinoma cells release the novel proinflammatory polypeptide EMAP-II in response to stress

Cancer Research

Volumn 60, Issue 11, 2000, Pages 2850-2857

  Barnett, Georgina ^a   Jakobsen, Anne Mette ^a   Tas, Maarten ^a   Rice, Katherine ^a   Carmichael, James ^a   Murray, J Clifford ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRESS; WESTERN BLOTTING;

ADENOCARCINOMA; ANTI-BACTERIAL AGENTS; ANTIMYCIN A; APOPTOSIS; BLOTTING, WESTERN; CELL HYPOXIA; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FLOW CYTOMETRY; GLUCOSE; HUMANS; IMMUNOHISTOCHEMISTRY; IONOMYCIN; IONOPHORES; MALE; NECROSIS; NEOPLASM PROTEINS; PEPTIDES; PROSTATE; PROSTATIC NEOPLASMS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; STRESS; THAPSIGARGIN; TUMOR CELLS, CULTURED;

EID: 0034214084     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tas, M. P. R., and Murray, J. C. Molecules in focus: endothelial monocyte-activating peptide II. Int. J. Biochem. Cell Biol., 28: 837-841, 1996.
2. Murray, J. C., and Tas, M. P. R. Endothelial monocyte-activating polypeptide 2: a novel injury signal? In: T. P. Fan (ed.), Antiangiogenic Strategies. Totowa, NJ: Humana Press, in press, 2000.
3. Nawroth, P., Handley, D., Matsueda, G., De Waal, R., Gerlach, H., Blohm, D., and Stern, D. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in methA fibrosarcomas. J. Exp. Med., 168: 637-647, 1998.
4. Kao, J., Houk, K., Fan, Y., Haehnel, I., Libutti, S. K., Kaylon, M. L., Grikscheit, T., Chabot, J., Nowygrod, R., Greenberg, S., Kuang, W-J., Leung, D. W., Hayward, J. R., Kisiel, W., Heath, M., Brett, J., and Stern, D. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II. J. Biol. Chem., 269: 25106-25119, 1994.
5. Kao, J., Ryan, J., Brett, J., Chen, J., Shen, H., Fan, Y-G., Godman, G., Familletti, P. C., Wang, F., Pan, Y. C., and Stern, D. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms. J. Biol. Chem., 267: 20239-20247, 1992.
6. Noguchi, M., Sakai, T., and Kisiel, W. Identification and partial purification of a novel tumor-derived protein that induces tissue factor on cultured human endothelial cells. Biochem. Biophys. Res. Commun., 160: 222-227, 1989.
7. Murray, J. C., Clauss, M., Denekamp, J., and Stern, D. Selective induction of endothelial cell tissue factor in the presence of a tumour-derived mediator: a potential mechanism of flavone acetic acid action in tumour vasculature. Int. J. Cancer, 49: 254-259, 1991.
8. Pötgens, A. J. G., Lubsen, N. H., van Altena, G., Schoenmakers, J. G. G., Ruiter, D. J., and De Waal, R. Measurement of tissue factor messenger RNA levels in human endothelial cells by a quantitative RT-PCR assay. Thromb. Haemostasis, 71: 208-213, 1994.
9. Tas, M P. R., Houghton, J., Jakobsen, A. M., Tolmachova, T., Carmichael, J., and Murray, J. C. Cloning and expression of human endothelial monocyte-activating polypeptide 2 (EMAP-II) and identification of its putative precursor. Cytokine, 9: 535-539, 1997.
10. Singer, I. I., Scott, S., Chin, J., Bayne, E. K., Limjuco, G., Weidner, J., Miller, D. K., Chapman, K., and Kostura, M. J. The interleukin-1β-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy. J. Exp. Med., 182: 1447-1459, 1995.
11. Knies, U. E., Behrensdorf, H. A., Mitchell, C. A., Deutsch, U., Risau, W., Drexler, H. C., and Clauss, M. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc. Natl. Acad. Sci. USA, 95: 12322-12327, 1998.
12. Nemoto, R., Hattori, K., Uchida, K., Shimazui, T., Nishijima, Y., Koiso, K., and Harada, M. S-phase fraction of human prostate adenocarcinoma studied with in vivo bromodeoxyuridine labeling. Cancer (Phila.), 66: 509-514, 1990.
13. Raghavan, D. Non-hormone chemotherapy for prostate cancer: principles of treatment and application to the testing of new drugs. Semin. Oncol., 15: 371-389, 1988.
14. Kyprianou, N., English, H. F., and Isaacs, J. T. Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation. Cancer Res., 50: 3748-3753, 1990.
15. Kyprianou, N., and Isaacs, J. T. Thymine-less death in androgen-independent prostalk cancer cells. Biochem. Biophys Res. Commun., 165: 73-81, 1989.
16. Martikainen, P., Kyprianou, N., Tucker, R. W., and Isaacs, J. T. Programmed death of non-proliferating androgen-independent prostatic cancer cells. Cancer Res., 51: 4693-4700, 1991.
17. Furuya, Y., Lundmo, P., Short, A. D., Gill, D. L., and Isaacs, J. T. The role of calcium, pH and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res., 54: 6167-6175, 1994.
18. Shimizu, S., Eguchi, Y., Kamiike, W., Matsuda, H., and Tsujimoto, Y. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene, 12: 2251-2257, 1996.
19. Nawroth, P. P., Stern, D. M., Kisiel, W., and Bach, R. Cellular requirements for tissue factor generation by bovine aortic endothelial cells in culture. Thromb. Res., 40: 677-691, 1985.
20. Shimizu, S., Eguchi, Y., Karniike, W., Waguri, S., Uchiyama, Y., Matsuda, H., and Tsujimoto, Y. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene, 13: 21-29, 1996.
21. Schluesener, H. J., Seid, K., Zhao, Y., and Meyerman, R. Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveilis. Glia, 20: 365-372, 1997.
22. Schwarz, M., Lee, M., Zhang, F. R., Zhao, J. S., Jin, Y. S., Smith, S., Bhuva, J., Stern, D., Warburton, D., and Starnes, V. EMAP II: a modulator of neovascularization in the developing lung. Am. J. Physiol., 276: L365-L375, 1999.
23. Quevillon, S., Agou, F., Robinson, J-C., and Mirande, M. The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. J. Biol. Chem., 272: 32573-32579, 1997.
24. Kallinowski, F., Schaefer, C., Tyler, G., and Vaupel, P. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res., 49: 3759-3764, 1989.
25. Movsas, B., Chapman, J. D., Horwitz, E. M., Pinover, W. H., Greenberg, R. E., Hanlon, A. L., Iyer, R., and Hanks, G. E. Hypoxic regions exist in human prostate carcinoma. Urology, 53: 11-18, 1999.
26. Ringenberg, Q. S. Vascular toxicity. In: M. C. Perry (ed.), The Chemotherapy Source Book, pp. 680-688. Baltimore: Williams and Wilkins, 1992.
27. Baguley, B. C., Holdaway, K. M., Thomsen, L. L., Zhuang, L. and Zwi, L. J. Inhibition of growth of colon 38 adenocarcinomas by vinblastine and colchicine: evidence for a vascular mechanism. Eur. J. Cancer, 27: 482-487, 1991.
28. Lazo, J. S. Endothelial injury caused by antineoplastic agents. Biochem. Pharmacol., 35: 1919-1923, 1986.
29. Schwarz, M., Brett, J., Li, J., Hayward, J., Schwarz, R., Kao, J., Chappey, O., Wautier, J. L., Chabot, J., Lo Gerfo, P., and Stern, D. Endothelial-monocyte activating polypeptide II. a novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells. J. Exp. Med., 190: 341-353, 1999.